Skip to Content

Biofermin Pharmaceutical Co Ltd 4517

Rating as of

Morningstar’s Analysis

Valuation
Currency in JPY
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Biofermin Pharmaceutical Co., Ltd. Manufacture and sale of pharmaceuticals, designated quasi-drugs, quasi-drugs, veterinary medicines, pesticides and other chemicals, cosmetics, medical equipment, foods, beverages, food additives, among others. Some of the company's products include Biofermin VC, Biofermin Pottery Intestinal Chewable, Biofermin constipation drug, Biofermin diarrheal stop, and others.

Contact
No. 1, No. 2, Sannomiya cho, Chuo-ku, Sannomiya Central Building, 12th Floor
Kobe, 650-0021, Japan
T +81 783322890
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Dec 31, 2020
Fiscal Year End Mar 31, 2020
Stock Type
Employees 240